Published in Anticancer Res on November 02, 2004
The mechanism of the anticancer function of M1 macrophages and their use in the clinic. Chin J Cancer (2012) 0.83
The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue. Drug Target Insights (2006) 0.75
Refractive error and ethnicity in children. Arch Ophthalmol (2003) 3.50
Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev (2004) 2.56
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell (2012) 2.01
The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev (2007) 1.84
Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum (2009) 1.77
Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res (2009) 1.71
Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med (2010) 1.66
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer Res (2007) 1.60
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood (2007) 1.51
Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Release (2006) 1.45
Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J Clin Invest (2014) 1.42
Survival and recurrence in nonmycosis fungoides primary cutaneous lymphoma. Cancer J (2009) 1.38
Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. Mol Pharm (2009) 1.37
Targeted drug delivery via folate receptors. Expert Opin Drug Deliv (2008) 1.33
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res (2013) 1.30
Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition. Proc Natl Acad Sci U S A (2013) 1.28
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharm Sci (2007) 1.27
Targeted delivery systems for oligonucleotide therapeutics. AAPS J (2009) 1.19
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents. Clin Cancer Res (2008) 1.17
Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability. Proc Natl Acad Sci U S A (2012) 1.16
A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest. IEEE Eng Med Biol Mag (2004) 1.16
Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting. Cancer Res (2003) 1.15
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer. Mol Ther Nucleic Acids (2013) 1.14
Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm (2007) 1.14
Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev (2004) 1.12
Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes. J Pharm Sci (2007) 1.11
Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol (2010) 1.11
Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion (2004) 1.08
Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J Control Release (2004) 1.08
A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care (2011) 1.04
A folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm (2006) 1.03
Tumour-selective drug delivery via folate receptor-targeted liposomes. Expert Opin Drug Deliv (2004) 1.03
Role of folate receptor genes in reproduction and related cancers. Front Biosci (2006) 1.02
Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing. J Control Release (2009) 1.02
Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release (2002) 1.02
Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 1.01
Imaging receptor-mediated endocytosis with a polymeric nanoparticle-based coherent anti-stokes Raman scattering probe. J Phys Chem B (2007) 1.01
The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery. Int Forum Allergy Rhinol (2013) 1.00
Genetics of the taste receptor T2R38 correlates with chronic rhinosinusitis necessitating surgical intervention. Int Forum Allergy Rhinol (2013) 1.00
Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug Chem (2003) 0.98
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. Int J Pharm (2010) 0.97
Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm (2010) 0.97
Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm (2007) 0.97
Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med Chem (2006) 0.97
Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res (2003) 0.97
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma. Int J Nanomedicine (2012) 0.96
Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol (2006) 0.95
Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion (2012) 0.95
Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells. Mol Pharm (2007) 0.95
The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells. J Biol Chem (2013) 0.95
Folate receptor-mediated targeting of liposomal drugs to cancer cells. Methods Enzymol (2004) 0.95
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine (2013) 0.95
Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. J Control Release (2013) 0.94
Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites. Blood (2003) 0.93
Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials (2012) 0.93
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells. Blood (2010) 0.92
R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism. Mol Endocrinol (2006) 0.92
A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm Res (2004) 0.92
Clinical translation of folate receptor-targeted therapeutics. Expert Opin Drug Deliv (2012) 0.92
Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem (2007) 0.92
AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut. Dev Biol (2010) 0.91
A novel pH-sensitive liposome formulation containing oleyl alcohol. Biochim Biophys Acta (2002) 0.91
Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med (2005) 0.91
During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein. Breast Cancer Res (2011) 0.91
Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT). Bioconjug Chem (2006) 0.90
Targeted nanoparticles enhanced flow electroporation of antisense oligonucleotides in leukemia cells. Biosens Bioelectron (2010) 0.90
Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation. Int J Pharm (2010) 0.90
Biodiversity and human livelihood crises in the Malay Archipelago. Conserv Biol (2006) 0.90
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease. Blood (2013) 0.90
Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs. Pharm Res (2014) 0.90
Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer Res (2002) 0.89
Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery. Bioconjug Chem (2002) 0.89
A facile microfluidic method for production of liposomes. Anticancer Res (2008) 0.88
Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats. PLoS One (2012) 0.88
Microfluidic methods for production of liposomes. Methods Enzymol (2009) 0.88
Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging. Int J Nanomedicine (2011) 0.88
Lyotropic liquid crystal systems in drug delivery. Drug Discov Today (2010) 0.88
Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release (2013) 0.88
Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery. Int J Pharm (2008) 0.88
SPANosomes as delivery vehicles for small interfering RNA (siRNA). Mol Pharm (2011) 0.88
Characterization of a novel diolein-based LPDII vector for gene delivery. J Control Release (2002) 0.88
Antitumor activity of G3139 lipid nanoparticles (LNPs). Mol Pharm (2009) 0.88
Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia. Mol Pharm (2010) 0.87
Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery. Anticancer Res (2011) 0.87
Continuous-flow cytomorphological staining and analysis. Lab Chip (2014) 0.87
A polyethylenimine-linoleic acid conjugate for antisense oligonucleotide delivery. Biomed Res Int (2013) 0.87
Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes. Anticancer Res (2006) 0.87
A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia. Nanoscale (2014) 0.87
Vascular targeting of doxorubicin using cationic liposomes. Int J Pharm (2007) 0.86
In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model. Anticancer Res (2005) 0.86
Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies. Clin Cancer Res (2012) 0.86
Cytokine gene polymorphisms and outcome after traumatic brain injury. J Neurotrauma (2013) 0.86
Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements. Mol Endocrinol (2011) 0.86
Molecular modulation of airway epithelial ciliary response to sneezing. FASEB J (2012) 0.86